Sigma Genetics

Sigma Genetics is a healthcare company located in Seattle, Washington, USA, with a team size of two. The company is part of the Y Combinator W17 batch and operates primarily in the United States and Canada. Sigma Genetics develops innovative devices that utilize magnetic fields to deliver DNA, RNA, and other charged molecules into cells. This technique is distinguished by its lack of arcing, scalability, and non-invasiveness, making it particularly suitable for in vivo applications. The platform technology has a wide range of applications, including cell therapies, cancer drug delivery, DNA vaccines, biopharmaceutical manufacturing, and cosmetics. Operating within the healthcare industry, specifically in the therapeutics sub-industry, Sigma Genetics is at the forefront of advancing non-invasive therapeutic technologies.